Share on StockTwits

GenMark Diagnostics (NASDAQ:GNMK) SVP Michael Gleeson sold 52 shares of the company’s stock on the open market in a transaction dated Thursday, August 7th. The stock was sold at an average price of $11.15, for a total value of $579.80. Following the transaction, the senior vice president now directly owns 177,600 shares in the company, valued at approximately $1,980,240. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of GenMark Diagnostics (NASDAQ:GNMK) traded up 0.54% on Friday, hitting $11.18. The stock had a trading volume of 122,187 shares. GenMark Diagnostics has a 52-week low of $8.48 and a 52-week high of $14.18. The stock has a 50-day moving average of $11.82 and a 200-day moving average of $11.23. The company’s market cap is $465.2 million.

GenMark Diagnostics, Inc (NASDAQ:GNMK) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.